Table 1 The case numbers and incidence rates of kidney cancer between 1990 and 2030 at the global level
1990 | 2017 | 2030 | AAPC (95% CI) of ASR | |||||
|---|---|---|---|---|---|---|---|---|
No. of cases (× 1000) | ASR (/100,000) | No. of cases (×1000) | ASR (/100,000) | No. of cases (×1000) (95% HDI) | ASR (/100,000) (95% HDI) | 1990–2017 | 2018–2030 | |
Overall | 207.3 | 4.72 | 393.0 | 4.94 | 475.4 (423.9, 526.9) | 4.46 (4.06, 4.86) | 0.14 (0.08, 0.20)* | −0.97 (−0.99, −0.95) * |
Sex | ||||||||
Male | 114.6 | 5.65 | 240.8 | 6.38 | 298.1 (270.7, 325.6) | 5.81 (5.29, 6.32) | 0.38 (0.30, 0.46)* | −0.82 (−0.84, − 0.80)* |
Female | 92.7 | 3.96 | 152.3 | 3.68 | 187.4 (171.3, 203.4) | 3.39 (3.11, 3.67) | −0.26 (− 0.30, − 0.23)* | −0.73 (− 0.75, − 0.72)* |
Age yearsa | ||||||||
0–19 | 27.0 | – | 24.4 | – | 18.4 (15.5, 21.4) | – | – | – |
20–39 | 17.0 | – | 23.3 | – | 21.7 (19.7, 23.7) | – | – | – |
40–64 | 90.3 | – | 171.5 | – | 189.6 (172.5, 206.7) | – | – | – |
65+ | 73.0 | – | 173.8 | – | 248.8 (226.4, 271.3) | – | – | – |